Amy Glekas

Amy Glekas is a seasoned professional in the life sciences industry with extensive experience in leadership and business development roles. Currently serving as Head of Field Development at Solvias since January 2024, Amy has previously held positions including Global Business Lead for NGS and RNA Modalities at MilliporeSigma, where ownership of advanced sequencing technologies was a key responsibility. Other notable roles include Global Head of Innovation at SGS and Business Development Executive at Catalent Pharma Solutions. Amy's educational background includes a Ph.D. in Biochemistry from the University of Illinois Urbana-Champaign and a BS in Genetics from Purdue University.